Reddit Posts
Canada Supplied 53% of Germany’s Entire Medical Cannabis Imports in Q1 2026 $HERB.CN/$LUFFF Quietly Building Real Momentum with Portugal Partnership
Canada Supplied 53% of Germany’s Entire Medical Cannabis Imports in Q1 2026 $HERB.CN/$LUFFF Quietly Building Real Momentum with Portugal Partnership
LightPath Technologies ($LPTH) - The Defense Tech Play Nobody's Talking About
LightPath Technologies ($LPTH) - The Defense Tech Play Nobody's Talking About
Should I just sell to kill the pain?
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
$RGBP Must read mRNA #FDA in play!
Why I Believe Charlotte's Web CBD Is About To Be Acquired by British American Tobacco or Organigram (DD inside)
OGI, OrganiGram Turns profitable and she’s taking off!!
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
Proposed Settlement Reached in 2016 Class Action (OGI)
I’m too poor to buy SPY puts, so I bought May 27th $39 SPYV puts instead. Am I retarted, or will there be tendies at the end of the tunnel?
In a competitive market, this little gem might seal the deal - - -OGI could very well be the best pot stock that will have you patting yourself on the back on this happy 420 day.
In a competitive market, this little gem might seal the deal - - -OGI could very well be the best pot stock that will have you patting yourself on the back on this happy 420 day.
Happy 420 Day! Buy This Top Pot Stock Now to Celebrate Later.
OrganiGram Holdings Inc. (NASDAQ:OGI) Receives $3.62 Consensus Target Price from Analysts
OrganiGram Holdings Inc. (NASDAQ:OGI) Receives $3.62 Consensus Target Price from Analysts
Thoughts on $OGI ? has earnings the 12th of April , possible cannabis federal legalization rally, RSI oversold in the hourly chart , would love to see ortex data if anyone minds sharing. Holding ATER in the meantime but gonna grab some cheap OGI calls today
Top Marijuana Penny Stocks For Q2 2022 By NATHAN REIFF, April 04, 2022. - HEXO, OGI, and SNDL are top for value, growth & performance, respectively.
Marijuana Opportunity Reinvestment and Expungement Act hits the U.S. House of Representatives floor TODAY April 1st 2022 🪴🪴🪴🪴🪴🪴🪴🪴🍀 Let’s BLAZE IT UP! 🚬😎
OrganiGram, OGI's inflow is fire 🔥 today!!
BAT increases Equity Position from 18.8% to 19.5% in OGI signaling confidence in the company.
BAT Increases in Equity Position from 18.8% to 19.5% in OGI
Some dude just told me you stupid apes can't get OGI to $10 today.... So I slapped that prick and said yes they can!!
🍃 🍃 Opinion on OGI, OrganiGram 🍃 🍃
Opinion on OGI, OrganiGram
Decibel and Organigram: The Next Great Short Squeezes?
Decibel and Organigram: The Next AMC and GME?
Thailand first in Asia to decriminalize marijuana. If you're not in Pot Stocks, you should take a look at some! OGI for me 💪
Pot stocks are on the rise this morning as hoped for!! Looking for a squeeze at OGI if you want yo join the fun! 💪🥳
OrganiGram an underated Canadian LP
Pandemic will be stopped by "herbs". $TLRY, $OGC, $CGC, $ACB
Flora Growth ( NASDAQ $FLGC ) Issues Guidance for Revenues of $35-$45M for 2022 as the Groundwork Laid in 2021 Pays Off and a New Processing Facility Goes Online. Current $1.75/share w/52 week high of $21.45/share.
Flora Growth ( NASDAQ $FLGC ) Issues Guidance for Revenues of $35-$45M for 2022 as the Groundwork Laid in 2021 Pays Off and a New Processing Facility Goes Online. Current $1.75/share w/52 week high of $21.45/share.
Watching $ACB, $SNDL, $TLRY & $OGI: Previous MJ Stock Short Squeeze Was in February 2021. Will History Repeat Itself? Short Sale Open Interest Report Due Tomorrow After the Market Closes.
So Now It’s OGI Time To Shine Remembers It’s About What Sells In The Canadian Markets And Well Organigram Brands SELL! Next Tilray?🤔
So Now It’s OGI Time To Shine Remembers It’s About What Sells In The Canadian Markets And Well Organigram Brands SELL! Next Tilray? 🤔
Pot Stocks are moving up today.
Go Big! Or Go Home Apes! VLNS is the Cannabis Stock for 2022
Regarding OGI's recent rise in market share
OGI ready for upper movement!
Tell me about your favorite company in the space right now
$OGI organigarm Marijuana Holdings is a great stock to invest. As senate is pressing toward legalizing Marijuana and the results are surely going to be high. So I tell my fellow traders and investors to get in into OGI. $OGI TO THE MOON.
Why isn't a cannabis stock pushed anymore? Like OGI...
My favourite little stock OGI is currently 1/3 of its YTD high and due a resurgence
Cannabis Stocks Are Ready To Launch
It's Time To Look At Cannabis Stocks...
It's Time To Look At Cannabis Stocks...
CANNABIS- we all smoke it. So how come WSB doesn't talk about the potential of this industry including TLRY, ACB, HEXO,OGI and obviously S$NDL
Dipping two of my 💎 fingers in $OGI. THOUGHTS? Put all of my allowance I saved up for 3 years lol 🦍
$SNDL $ACB $OGI - Could it be there time to make a move?
I picked up some Nokia and OGI, is it worth keeping, holding, or selling. I figure cannabis for OGI would hit big time soon. Is it a #HODL or sell. I am thinking it could explode big time
Anyone see anything good from Nokia or OGI cannabis stock
Sundial Potential Short Squeeze is Coming
Thoughts on SNDL Sundial Growers? Also OGI OrganiGram?
Mentions
OGI bottled the Motif acquisition. They lost a lot of the vape market share to Cronos and flower share to Village Farms.
Yeah OGI has been taken to the woodshed by BAT. The Sanity Group deal was an abomination. But even before that deal, OGIs profitability took a sharp turn. Unfortunate as they have some of the best indoor production assets and brands in canada. I hadn't realized CRON started posting positive FCF. Looks like their NI is still hit or miss, but they have the best balance sheet in the entire industry.
XLY, LOVE, CRON all make money and are growing organically. Used to be OGI but idk wtf happened to them they went the opposite direction. Could add decibel to the list to replace OGI but seems riskier than the others.
Very likely and am waiting as well. RYM, TSND and CL will be my plays. I've already bought into HITI and OGI the last couple of weeks.
OGI getting hammered the past couple days. They are now a lower market cap than Cannara Biotech. OGI - 172M LOVE- 187M
yes and no? OGI probably is undervalued, but that doesnt automatically make it the best place to park cash right now. with the S3 hearing coming up, there are US companies that are much more directly exposed to the outcome and will probably move more if it goes well OGI has some US exposure and BAT’s backing helps, but it’s still mostly a Cad and international company. solid company? perhaps. most exciting S3 play? probably not I’d rather keep the cash available for companies that actually stand to benefit directly from the hearing instead of buying OGI and hoping the whole sector drags it along for the ride
Cweb and OGI both down significantly, definitely not a coincidence...smh
I've been on the sideline looking at this stock for some time now Here are the bad things I noticed: \- like all LP their cad business is not doing well, net fell by 9%, margin declined by 2% to 31%, adjusted EBITA fell 82% to just 0.9 mil CAD. And free cash flow was negative at 7 mil \- dilutions that may or may not happen due to the sanity acquisition \- lost another 5.8 mill due to the hemp THC business dying in the US good things I noticed: \- probably still no 1 in the Cad market for rec cannabis? \- sanity's revenue gross margin last year went from 15% to 47%, so it's a good acquisition, OGI said they are expecting around 25 mill EURO in average quarterly revenue over 2026 \- BAT is still committed just my own 2c
I just keep buying this OGI dip
I just got **all in** again on this one, doubled my money 2 times on OGI since covid on false corrections like are happening now (near 52 wks. low). Massively underpriced compared to other cannabis stocks and in my mind one of the only safe bets due to being backed by British American Tobacco. **Huge catalysts that will make this stock explode or at least regain it's price (double):** \-Current Market Cap ($CAD) +/- 195M, 2026 Guidance 350M+ \-Currently undervalued due to a sector wide correction non related to this company. \-They acquired several companies in legal markets (Canada, Germany) as well as the USA. \-Q3 (August 12th) will have a big revenue increase due to their buyout of Sanity Group in Germany's legal market (added revenue) \-USA ALJ DEA hearing (due date July 15th) for schedule 3 going in favor of Cannabis which will drive institutional investment later on as it finalizes & raise cannabis stocks as a whole later this month. \-BAT keeps investing in OGI at a strong double (true) valuation & who knows, they could acquire OGI completely later on (for long term investors). \-& tons more don't want to make this a book, you get the point, as always do your own research & draw your own conclusions, thought I'd share my recent research on this overlooked stock! This time there are much more catalysts than the last times I was invested in it.
Why is this subreddit obsessed with trashing Tilray for dilution? 1: ACB total diluted shares- 7.43 billion (!!!) 2: CGC total diluted shares- 4.14 billion 3: SNDL total diluted shares-2.5 billion 4: HITI total diluted shares-1.32 billion **5: TLRY total diluted shares- 1.05 billion** 6: OGI total diluted shares- 563 million 7: CRON total diluted shares-375 million I am the first one to criticize Tilray, but my god the obsession with that company on this subreddit when the vast majority of cannabis companies are disasters and many are more or just as dilutive is just so obnoxious and stupid. And don't kid yourself, if MSOs had the same access to the larger market they would be digging into equity as well. It's free money as far as these companies are concerned, and when things open up more in the USA like in Canada, the competition will become extremely aggressive and the need for funds to grow and keep up will be vast. There isn't some inherent dilutive gene trait in all of the Canadian companies that US companies don't have.
OGI, trading at approx. 0.5-0.6x price to guidance for 2026 (conservative numbers), big events coming in cannabis, they're buying out big players in legal markets of Europe/Canada & USA, backed by BAT. Incoming Sch. 3 USA June 29th-july15th, big jump in revenue coming in Q3 Aug 12th from acquisitions, read on it yourself its on the way for a double or higher, was up 7-8% Friday from its 52 week low, now is the time! Ive 2x my money on this one already 3 times since covid!
OGI had a big wall at 1.45 bud. and it’s gone
You do you - this is not a support group for investors struggling with exposure and allocation. In saying that…right size your bets, reduce doubt by sorting out what you’re actually buying and know why you are convicted. Most would disagree with me but I just hold MSOS/MSOX and fluent for USA exposure. I hold HMMJ and OGI for cad exposure. It’s your money - buy a happy meal or a couple more shares of GTI - whatever makes you…happy
I mean Auxly’s margins are above 50%. Better cash flow from operations than either of these companies. What you’re seeing is terribly run companies are continuing to fail. Other companies like OGI, Tilray, etc have way too many brands, too many different sites, where products need to be transferred all over the place and the cost to make it is way too high cutting into their margins and ultimately not being able to be profitable. You can’t lump all LP’s into the same category. Are a lot of them garbage…yes. You have to prove it in financials and I just haven’t seen it yet from Hitide. Seems the same as when OGI acquired Motif, every quarter it was next quarter you’ll see the synergies, next quarter. And they look worst than ever on their latest earnings. Hitide to me seems the same. No margins, so when everyone talks price to sales ratio, means nothing.
OGI making a good recoil with a double bottom. Would expect a significant runup if the volume picks up. Lots on the go would not be surprised to hear some news soon.
They'll "catch up" because OP has heavy OGI bags. It's all they post about. Baseless pumping.
Interesting how CL and OGI have not caught up yet. Only a matter of time until the masses notice. Sometimes a little news release helps with some visibility.
I can't day trade but if I could then I'd do TSND as it's right on the cusp of a break out. Cl needs to break 1.30s and OGI needs to consolidate and can go either way till it stabilizes.
I can't day trade but if I could then I'd do TSND as it's right on the cusp of a break out. Cl needs to break 1.30s and OGI needs to consolidate and can go either way till it stabilizes.
Thanks. It’s either OGI. Back into CL or green thumb I feel green thumb is the golden child and I may park it there for a bit. I missed TRUL I jumped out around 10 and kick my self
lol. I bought as well sold all my OGI all in Cresco.
Trul uplisting is the first domino to fall and the next one would be an acquisition either by the likes of Tilray, BAT/OGI or Cronos to kick start some much needed excitement for this pos sector. Glta
OGI quiet but that will change ! Good luck all.
OGI is the one everyone will say why didn't I invest in it while it was close to 1us.
OGI was so beat-up last earnings was already priced in a while ago. Lets see where this goes.
Right now OGI last week. Cura and green thumb for a nice bounce
I went to OGI headquarters the oher day. Impressed. They are global for sure and have no issue with thowing a few dollars at this time when the stock is beat up. Good luck all.
OGI is ready for something. Are you?
BAT now owns 40% of CWEB after the their conversation that received shareholder approval. I am just hoping that they let CWEB run on its own and not make it into another OGI.
Bat will buy CWEB and OGI
Very likely. I say this with OGI being own of my core positions. This dips is where I just keep adding to the pile. Eventually BAT will come for all of this and than some..
OGI red. Only one all day. Poor thing
No ties to the industry whatsoever. I couldn't be more of a nobody. Just a regular dude with too much time on my hands. I believe as much as anybody that this is a once in a generation market that is opening up though. It's a very unique opportunity, but I am also very aware that we are not the only ones who know this opportunity exists. Cannabis is one of those things that really does transcend class and culture. Me and the billionaires smoke pretty much the same product. But the billionaires are also smoking with some of the richest and most brilliant and least ethical financial minds in the world. There is no chance there aren't plans for cannabis going on in the background. People like Peter Thiel and Roman Abramovich haven't been investing in the cannabis industry for a decade without having some sort of guiding hand on policy. These people play a totally different game than us. With totally different timeframes and goals. To achieve those goals, I think the Jack Abramoff style lobbying schemes are going stronger than ever, with those sort of deals being extremely common in our industry. Jack Abramoff himself got charged with undisclosed lobbying for a cannabis firm from 2017. Not only do I find it fascinating to dig into insider connections, but it has been lucrative for me trying to get ahead of their moves. Taking a more macro-oriented view of the space led me to have a very large portion of my investments in CWEB prior to Trump's move on CBD. Following the sketchy insiders led me to an amazing trade opportunity with penny stock Stem Holdings where I turned like $500 into $15,000 in a week. Stem Holdings later turning out to be a direct investment by Jeffrey Epstein (fascinating stuff!). My research has led me to companies I'd never have heard of otherwise, and given me confidence to take risks in precarious situations. Like when everyone said not to average down on Glass House when they crashed after the immigration raid. Or to go hard into OGI after they reverse split last time, because I knew BAT was lurking waiting to make more moves. I certainly wouldn't claim to have always made winning investments, but I am very confident I'm doing better than the vast majority of people here. And I attribute a lot of that to learning about the sector independently, while avoiding social media and trusting in myself, rather than what an influencer is trying to get me to do.
Another Day to buy more OGI
I've been some through this week adding to my OGI and Cl positions. I will add more next week if there's further correction in these names, an easy 30% up from here when the next set of news drops in Jun. Glta
I look at MACD largely to buying and looks like we will go down a little more and consolidate here..I have been buying them OGI and Cl through this week..will add more next week on TSND if it drops a bit more or tests it's previous lows in 70s. Glta
The companies that are seeing the best growth in the country are all private companies. OGI was the largest at about 10% of the total market, but they've lost as this report says about 10% since last year. Auxly and Cronos have probably seen the greatest gain from those losses. However, the top 10 producers in the country only account for about half of the total product sales.
Definitely a bad quarter, but they've had bad Q's in the past and adjusted and done fine afterwards. Like when the high THC stuff was getting dumped on the market. Even with such a bad quarter, they're not actually losing that much money, especially compared to what BAT has invested recently. So the sky isn't falling. BAT will find a way to give them a little more money if they really need it, but just turn it around slightly next Q and they'll be totally fine. Just always be taking some profits on pumps, so you can be ready for any situations like this. Not much else to say about Canada rec, other than hopefully they adjust like they did in the past. Nobody is making tons of money there, even the profitable companies. If OGI could make tons of money in Canada rec that would be great. But tiny Canada is just a staging ground for international medical and hemp and stuff. Still waiting on that EU-GMP certification at their one facility I see. I don't think turning their Canadian recreational into a cash cow is really the end goal. More like R&D and product development that hopefully doesn't lose too much money. BAT is looking towards the US, EU, and eventually places like India, where BAT has a significant presence. Even if they completely dominated Canada it still wouldn't be that big of a win for BAT, with their market cap >$100B. BAT only cares about the big markets in the long term. It's funny that some people seem to think OGI is in some serious trouble as a company, like on the path to go out of business or something, when BAT is has been making all these moves for them. Not like BAT thought they were going to buy Sanity and then just coast on profits the rest of the way, regardless if this one Q was good or bad. BAT has been invested in Sanity since 2022. Way before they had OGI follow up on their investment. They knew they were running OGI's cash super low with that move, but they also knew exactly what they were investing into. So we'll see. More moves are certainly on the way. I have no reason to think BAT is just planning on OGI to organically grow from where they are at this moment. Now one specific thing I thought was interesting is that OGI seems to have written down about $6M in hemp investments in the US. >In addition, the current period results were negatively impacted by a $5.8 million impairment loss related to the Company's hemp-derived products business in the U.S. But BAT was also separately investing more into Charlotte's Web recently, who pretty much only do hemp in the US? Maybe it was just a NASDAQ thing where OGI had to write it down before the ban actually happened? Idk. Just thought that was an odd thing between the two BAT companies.
Makes sense with how the current admin is focused on cannabinoids as a headline item as opposed to MJ/Cannabis... Btw what's your take on OGI's ER from earlier today.
All the other companies are paying for shelf space as well and can still be profitable. OGI’s problem is that they are spending more money on a bloated sales team and they’re selling less YoY.
Hard to blame consumer confidence when both VFF and Cronos posted decent quarters. I think this is a OGI specific problem. They are losing marketshare. Rubicon and Auxly also report this week which will provide some valuable context
This is a rough report. The only thing up year over year is their inventory and excise stamps went down 10% YoY, which means their Canadian sales are falling a bit faster than revenue. OGI is a sinking ship and will probably need to make some major changes to even right size the business.
They own several brands. I Believe Spinach is the number 1 vape brand. But with all their brands combined OGI is the overall number 1 producer Organigram has: Boxhot Edison Trail blazers Rizzlers Debunk And a few more
Extremely rough. I didnt realize OGI was derailing this badly. On a sidenote they should really stop adjusting R&D costs out of their EBITDA. And acquistion costs for that matter. Nearly 7 million of costs here that they just say 'well not important for profitability'. Thats the most brazen creative accountancy i see in this sector. These are ongoing costs, its embarassing as hell.
OGI tomorrow. Anything spicy ???
I Say Bat will take over OGI with in 2 years
IIPR - yeah, but always going to be able to trade cannabis real estate assets, JAZZ - proven, medical efficacy, OGI - backing from big tobacco, GTI - best in class in the United States. Trul - Florida medical I guess.
OGI. Everybody is waiting for big tobacco or alcohol to pump their favorite MSO, but it's already done with OGI and every sign points to a long term partnership to build out Europe and the US. A steal at current valuation.
Tbf, I didn't say they *currently* control everything. But right now remexian has the largest market share and Sanity, based on what I read from the OGI acquisition, has a large market share too. The LPs themselves will keep moving their product, but there's absolutely going to be consolidation with the importers. The smaller importers are going to struggle as price compression continues and the big players will gobble up market share.
I used GTI/RYM/CRON simply.as an example, given their existing structure, spinouts, and cash on hand. Not at all suggesting that deal is likely, or even makes sense. Just a structural example. Agreed that Sundial is a company to watch on this. Cronos as well. Likely a few others that I don't follow as closely (OGI via BAT?).
What are your thoughts on OGI, Organ a gram?
Yup. ACB and OGI were my plays back in Dec before the EO hype cycle kicked in. I see ACB is starting to catch a bid and OGI just started moving the couple of days now.
Agreed on your observation and it seems (mini hype cycles) to be the way this sector has been operating since Aug 2023. Early on in Jan this year I was expecting something concrete to emanate by the end of Jan/Feb, but given how this has played out so far I have very little faith of seeing anything substantial before June. I am still open to buying though this period but only for quick swings and don't plan to add to my core positions (except GTI, OGI and HITI) until we see something more tangible. Glta
Hypothetical question : At some point would it make sense for OGI and CWBHF to merge? Would that make sense for shareholders?
BAT now owns big chunks of OGI-CWEB and VFF Big time ex-BAT executives populate top positions at 2 of the 3 firms BAT is a 126B firm
BAT invested in Sanity Group before High Tide. The OGI investment was a follow-up to BAT's original investment. [https://www.bat.com/media/press-releases/\_2022/september/sep-26---bat-announces-sanity-group-investment](https://www.bat.com/media/press-releases/_2022/september/sep-26---bat-announces-sanity-group-investment) >This investment is complementary to other recent investments made by BAT or BAT companies, most notably the strategic R&D collaboration established with Canada’s Organigram Holdings Inc. announced in March last year. The stake in Sanity Group adds a European dimension to one of the many BAT explorations beyond nicotine.
Alcohol sales way down and dropping, tobacco’s in the same place. Why do you think Bat is invested in OGI ? Why do you think OGI’s CEO is from BAT. Won’t be long until Bat buys them out and takes over. Disclaimer not in OGI
Yea whenever people were saying they were getting low on cash I was never worried because this kind of investment is like coins in your couch cushions for BAT. They had their first investment, then a follow on for their CBD drug joint venture, plus all the money they were dumping into OGI. No reason for them to just sit by and let CWEB run out of money. From financials press release: >*Following completion of the Transaction, BAT will hold approximately 40% of the Company's then-issued and outstanding common shares on a non-diluted basis.*
He mentioned they'll be rolling out a roster of Canadian Brands in June who will be selling exclusively through Remexian in the German and UK markets. If I had to guess it will be all the big boys (TLRY, ACB, VFF, CGC) and a few smaller players like LOVE trying to build a bigger international precense. The largest exception will be OGI as they have their own importer in Germany, and CRON is a wild card because they do have CanAdelaar in the Netherlands.. I can't speak to their ability to leverage that for German imports. He also mentioned that Nuleaf Naturals is GMP and FDA certified and meets all the requirements for the CBD Medicare pilot. Sounds like there's a good chance they'll be able to partake in that right out of the gates. He cautioned that revenue growth should be expected there until 2027/2028, not sure why. Also, it seems that importing to Germany from Canada is proving more time consuming that originally thought, since our first shipment expected the first week of March is now expected to be 30 days late. However we have been successful in importing product from South Africa, Thailand, Malta, and Czech Republic recently.
CRON, OGI, Auxly, and Decibel are also not down that much today.
To be fair, none of Tilray’s recent acquisitions have been in the cannabis space. Nor do they need any more brands or capacity in Canada. With that said, it looks like OGI, VFF and Tilray have all claimed the lead in flower sales within recent months. I don’t expect any to take a substantial lead without further consolidation in the Canadian market.
Motif was a big jump for Canada. Sanity doesnt change Canada. But OGI feels like they stalled out on organic growth and started overpaying in M&A. Now a Tilray v OGI race for market share through M&A.
Just in flower. OGI claims overall market share. Vapes & pre-rolls are a growing portion of overall market size. I dont think pre-rolls are part of flower because VFF isnt very strong in pre rolls.
from vff cc ysy: Sam Gibbons: Aaron, just a couple of things to add. We did regain our #1 flower share position in January. And we expect that to be something you'll continue to see in 2026 Didn't OGI leapfrog everyone with their last M&A? Was surprised to hear this..
This acquisition is great news, I see some worry in the comments about dilution, this isn't a Tilary style Dilution to raise addition captial or some flashy acquisition for hype. This acquisition is our key to the European market, without sanity it would take 5 to 10 years to enter this extremely restricted market. We our also gaining market share in sanity which if things play out will not be much of a dilution if you add in the gained market share. This is a win win for OGI shareholders.
I would agree that OGI has the right thought process on some aspects of their business and believe that they message well externally to investors. However, IMO as a Canadian that buys cannabis I think there is a gigantic disconnect with how investors see success in the sector and the reality on the ground. I’m not currently invested, but I have in the past and have owner OGI. Overall I’ve made money through cannabis but when I’ve profited it’s consistently been due to riding the wave well and selling at the top. The underlying structure of the businesses I had invested in were unchanged or worse. Success in the sector is like 90% luck. Therefore I watch this sub more to track sentiment. OGI is one of the most interesting companies to track because I feel like everyone here acknowledges that the company is burning cash and structurally flawed, but everyone invested relies on being able to buy in below BAT. I don’t see anyone questioning why we should assume BAT knows what they’re doing within the sector.
Most likely how OGI "conducts themselves" is a BAT company thing. I have done work for 3 of the largest tabacco companies and BAT was leap years above the others in the way they conducted business. Marketing professionals vs cowboys who could not get hired at BAT. The Phylos deal with THCV (skinny weed) was a BAT deal directed at women who used to smoke to suppress their appetite which was 50% or so of their tabacco market. Their THCV gummies have saved many bags of chips lives at my house.
Agreed. I'm not pitching OGI as an investment, I only mentioned them due to their "caliber". They conduct themselves like a mature enterprise. Overall you're right that consumers only care about the highest THC at the lowest price. I don't invest in growers because there is simply too much competition and the costs of growing are too high. HITI sells their own brand called Queen of Bud. They source the cannabis from LP partners to develop their brands just like in any other mature industry. That's a model I can get behind.
At this time health focused Cannabis products do not sell well in Canada. Only way I see that changing was if Health Canada changed the rules to allow drug stores to sell cannabinoid products or if they removed the laws to allow for health recommendations. However, both of those changes would help the industry as a whole and not just OGI.
OGI's exclusive partnership/agreement with Phylos is an important one as well. I think BAT will eventually bring all its cannabis ventures globally under OGI umbrella and build it as a growth engine for the future (esp with declining preference for tobacco as a sin).
Yeah I don't invest in growers. However the work that OGI/BAT has done including science backed products like FAST and other innovations like jolts, shots, etc is interesting for a newcomer looking in on the industry. They conduct themselves at a high level compared to their peers.
> Check out what OGI is doing and their relationship to BAT. OGI probably has the closest thing in the industry to a futuristic CPG portfolio. Unfortunately their financials are problematic and BAT will likely acquire them before shareholders have a chance to profit. OGI have also been losing momentum with their products and are sitting on excess inventory. Domestic sales in Canada fell YoY in Q4 when you include Motif’s revenue and they’re losing further market share to Cronos since that happened. I think there is opportunity in Canadian cannabis as an industry, but it’s not going to be found in the currently publicly traded companies.
It's an ugly, ugly sector. Most people here are fooling themselves if they think the MSO model in its current form has any staying power. My advice is to stay away for 10 years if you are mainly interested in investing in the US. There's a lot of disruption and hard reality still to come due to the large patchwork of state-run programs. Some of the best companies out there aren't even public. (Wyld/Grön comes to mind) However if you're interested in the global, and federally legal market it would be worth considering HITI for your portfolio. They have 220 retail stores in Canada and a German import business. Both segments control 12-14% share of their respective markets. They've been free cash flow positive for 3 years and even have some inroads to the US CBD industry through their subsidiaries Nuleaf Naturals and Fab CBD. Personally I wouldn't invest in growers Canadian or US. Cannabis is a commodity and farmers will always be the last to profit in the long term once markets mature and prices stabilize. Check out what OGI is doing and their relationship to BAT. OGI probably has the closest thing in the industry to a futuristic CPG portfolio. Unfortunately their financials are problematic and BAT will likely acquire them before shareholders have a chance to profit. For the love of God stay away from CGC and TLRY.
OGI just overpaid so badly though. That deal was insane
VFF, Cronos, Aurora, Aphria, maybe OGI
**Global Expansion Strategy/Philosophy** >**Zuanic:** Can you explain, in the context of the consolidation we are seeing in Germany--High Tide and DEMECAN, OGI, Sanity--why was Holland a priority over Germany, especially with the market consolidating and some distributors still being available? > **Gorenstein:** When I look at Germany, the first thing is, there’s still regulatory uncertainty, and you’ve got some movement that’s going through. We expect in the coming months to get certainty. I also think when you look at availability of licenses, you know, distribution and opportunity to get into the market, there’s plenty of opportunity to get in. There are many options there. > From a business model perspective, it can be difficult because some of the distributors that you look at buying, they have many brands on the platform, there’s a lot of different distribution, and you’re not sure if you’re picking up a business, are you still gonna have that distribution business because they’re distributing your competitors. It’s something we continue to evaluate, think about the smartest way that we could deepen our presence in the market. We thought the Netherlands was much more sort of on strategy. It’s a market that, without making a acquisition, we would have no way to get in because it’s closed as far as import/export. It has its own supply base, its own brands.... > You know, we feel like it’s not a step towards getting towards adult use and building a brand. It’s moving directly into the adult use market in a place where you’ve had a 50-year history of adult use sales, and we think gets the most brand leverage for any market across Europe, just given the kind of culture and history around the Netherlands coffee shops. So we thought it just made a lot of sense, and it was a really unique opportunity for us. > **Zuanic:** Just a quick follow-up: Look, I mean, in markets like Australia, we’ve seen operators, distributors taking control of downstream assets, whether it’s clinics or even online pharmacies. We’re beginning to see that in Germany, apparently, and it’s happening in the U.K. I mean, Curaleaf owns a clinic there and an online pharmacy. How do you think about downstream opportunities, medium, longer term, or is that something that you prefer not to be involved in? > **Gorenstein:** Thanks. It’s a great question. I think we take a really long-term view on any acquisitions and capital spend, and I think it can be market specific, but I’m always looking at where do I think the market’s gonna end up? And if it’s something where it’s a more temporary business or we’re worried regulations are gonna change it’s something where we prefer to be a customer than an owner of the asset. But if I think it’s gonna be locked in for longer and we can model it out and see there’s a long-term payback to being an owner versus a customer, then it’s something we would consider. I think it’s really market specific. But I do go back to the experience we saw early in Canada. If it’s a market where we think it’s gonna go adult use, or if it’s a market where we think that regulations can change, you know, what that funnel looks like, it’s something we would rather just spend the money to help with marketing and demand versus be sort of an owner of that part of the funnel. [Conference Call Transcript](https://in.investing.com/news/transcripts/earnings-call-transcript-cronos-group-q4-2025-sees-revenue-miss-stock-down-93CH-5260546)
Canadian names going green today - ice move on jazz this week - need chron, OGI and IIPR to pump now.
This 🤡 likes to say it’s easy but I recall him saying he bought 10000k shares of OGI and how things were “predictable”. Funny thing tho…when he claimed to buy those OGI shares would be a SOG ficant loss rn, so he’s doing it wrong but pretending like he’s doing it right. I actually don’t believe he’s doing anything but posting comments tho.
It seems OGI was pressured into this purchase by BAT to fulfil their international vision.
> OGI doesn't have the skill-set or the motivation to run a large-scale German cannabis import business Sorry, but how do you figure that? I agree that OGI is a pretty inefficiently run, top-heavy company but how would they not have the "motivation" to operate this business they just bought?
lol I don't believe you for a second. There have been like 5 months total in that 3 year period that have been below today's price. You would have had to pretty much only buy during those exact periods to be up on your OGI average. The fact that you say DCA and swing trade in the same sentence is hilarious. Which one? They are antithetical. My guess is "DCA'd" down from your initial purchase at \~$4 then swing traded a on pump to "reset" your average - ignored that loss then bought a bunch when it dropped again and claim that as your average. Also humorous that your flex is investing in a different company than OGI...one that's losing a ton of money and pumped on vibes. Hope you sold out cuz they are outta cash within the next 2 quarters. PS: BAT IS the creditor that may wipe you out...
I mean.... you've lost more than 50% of your investment over 3 years if you bought OGI so I'm not entirely sure it's a flex. The past 1 year they are flat... Maybe there's upside but they are still losing money in Canada and are now taking on more complexity over seas. Could be some upside but the risk to the downside is enormous
There was news this morning. BAT is buying topping up their stake in OGI... In other words dilutive financing.
I know you are trying real hard to be negative about everything, but you're talking to the wrong person. I have talked about their financials many many times, going back years. Here is me talking about financials [three years ago](https://www.reddit.com/r/weedstocks/comments/14zc8gu/comment/jrx7nsr/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button). Notice I don't shy away from highlighting negatives too. >OGI with the run into financials and dump after again. **Margins got crushed**, being blamed on a large increase in "30%" THC flower on the market all of a sudden. Regardless, they need to fix it. Not too worried, as they will survive due to cash/debt. >Big impairment took a lot of goodwill off the books. **Real net loss like -23M**. >The **$75M cash and negligible debt** are the primary things I care about right now. That and waiting for CBD laws to get clarified, or for BAT to do something. Here's another from [years ago](https://www.reddit.com/r/weedstocks/comments/14zc8gu/comment/jrxh563/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button). Notice I am following BAT's pursuit of hemp in particular, even years ago before anybody was talking about it. >As I stated, my preference is based on their cash/debt and the continued evidence that BAT is serious about making moves into CBD in particular. $75M cash and negligible debt is very good if they are able to correct their margins. Besides CRON, they are practically the only cannabis company I am very confident will "survive" whatever hardships the market faces. >But I'm sure there will be a lot of very dramatic people here today who think I'm here for the short term and will criticize. Don't day trade this sector. You will lose all your money. How long have you been here exactly?
This is about the headline and making OGI seem like a swinging dick to outside investors, not about any actual fundamentals (which, as you note, are not really there). The German market has seen incredible growth in the past few years but it's trajectory is slowing down and there are domestic producers like Tilray/Aphria and Aurora and Demecan are pushing back against exports and the German regulators are listening. Companies like Organigram and others have already lost a lot of weed to this, largely through increased enforcement in Portugal. Anyone following this market closely is well aware of these issues. But retail investors and others just trying to not miss out will leap before looking.
> People investing in OGI are doing so in large part due to BAT's deep pockets and their continued commitment to OGI. That's kind of a funny way to admit you aren't investing in them based on any actual fundamentals like earnings. Without BAT's deep pockets, this company would be bankrupt. But just like Canopy and the others back in the day, that spending ends at some point.
Which is exactly why it will fail. OGI doesn't have the skill-set to run a large-scale German cannabis import business, even with BAT at the table. Remexian is going to eat their lunch.
Ya given BAT's ownership in Sanity, this feels like it was BAT pushing this rather than an OGI strategic goal
compare to the multiple that HITI paid for remexian (2.9x ebitda IIRC) and Cronos paid for Candelar (2.4x ebitda IIRC). Those were ebitda multiples not revenue and are close to the revenue multiple OGI paid before the 100% earnout! Feels like BAT had to invest at a premium to convince OGI to do this.
Not inherently negative as they got a premium to current price but if all marks are met it would dilute the current OGI shareholder by 42% for under $100m in '25 revenue. Lots of risks involved
If it were just OGI making an acquisition with existing assets, then the typical pattern would be more likely. However since this is BAT making a move just as much as OGI, i don't think it's directly comparable to a typical acquisition. It could still go down though once the deal is digested a bit.
Bought ITM OGI calls furthest expiry available - October, last week. With BAT backing, I thought it a decent risk. Typically the aquiring company falls, but I guess the market likes this aquisition. We'll see how long it holds.